<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p29" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_29{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_29{left:341px;bottom:30px;}
#t3_29{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_29{left:377px;bottom:30px;}
#t5_29{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_29{left:540px;bottom:30px;}
#t7_29{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_29{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_29{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_29{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_29{left:285px;bottom:827px;letter-spacing:-0.26px;}
#tc_29{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_29{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_29{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_29{left:1109px;bottom:28px;letter-spacing:0.29px;}
#tg_29{left:36px;bottom:183px;}
#th_29{left:46px;bottom:177px;letter-spacing:0.13px;word-spacing:-0.06px;}
#ti_29{left:331px;bottom:177px;}
#tj_29{left:36px;bottom:166px;}
#tk_29{left:42px;bottom:160px;letter-spacing:0.13px;}
#tl_29{left:257px;bottom:160px;}
#tm_29{left:36px;bottom:149px;}
#tn_29{left:42px;bottom:143px;letter-spacing:0.09px;}
#to_29{left:45px;bottom:127px;letter-spacing:0.08px;word-spacing:0.01px;}
#tp_29{left:45px;bottom:110px;letter-spacing:0.1px;}
#tq_29{left:128px;bottom:110px;}
#tr_29{left:174px;bottom:778px;letter-spacing:0.46px;}
#ts_29{left:174px;bottom:760px;letter-spacing:0.45px;}
#tt_29{left:36px;bottom:544px;letter-spacing:-0.1px;}
#tu_29{left:36px;bottom:525px;letter-spacing:-0.07px;}
#tv_29{left:36px;bottom:507px;letter-spacing:-0.09px;}
#tw_29{left:36px;bottom:489px;letter-spacing:-0.12px;}
#tx_29{left:36px;bottom:470px;letter-spacing:-0.1px;}
#ty_29{left:97px;bottom:478px;letter-spacing:-0.09px;}
#tz_29{left:36px;bottom:452px;letter-spacing:-0.08px;}
#t10_29{left:36px;bottom:434px;letter-spacing:-0.12px;}
#t11_29{left:36px;bottom:415px;letter-spacing:-0.09px;}
#t12_29{left:174px;bottom:728px;letter-spacing:-0.09px;}
#t13_29{left:174px;bottom:710px;letter-spacing:-0.1px;}
#t14_29{left:174px;bottom:692px;letter-spacing:-0.1px;}
#t15_29{left:174px;bottom:673px;letter-spacing:-0.09px;}
#t16_29{left:174px;bottom:655px;letter-spacing:-0.08px;}
#t17_29{left:174px;bottom:637px;letter-spacing:-0.1px;}
#t18_29{left:174px;bottom:618px;letter-spacing:-0.09px;}
#t19_29{left:174px;bottom:600px;letter-spacing:-0.09px;}
#t1a_29{left:174px;bottom:527px;letter-spacing:-0.09px;}
#t1b_29{left:174px;bottom:508px;letter-spacing:-0.07px;}
#t1c_29{left:174px;bottom:490px;letter-spacing:-0.1px;}
#t1d_29{left:174px;bottom:472px;letter-spacing:-0.09px;}
#t1e_29{left:174px;bottom:453px;letter-spacing:-0.08px;}
#t1f_29{left:174px;bottom:435px;letter-spacing:-0.1px;}
#t1g_29{left:174px;bottom:417px;letter-spacing:-0.09px;}
#t1h_29{left:174px;bottom:398px;letter-spacing:-0.09px;}
#t1i_29{left:177px;bottom:279px;letter-spacing:-0.09px;}
#t1j_29{left:177px;bottom:261px;letter-spacing:-0.11px;}
#t1k_29{left:316px;bottom:710px;letter-spacing:-0.1px;}
#t1l_29{left:419px;bottom:718px;}
#t1m_29{left:316px;bottom:692px;letter-spacing:-0.09px;}
#t1n_29{left:316px;bottom:673px;letter-spacing:-0.06px;}
#t1o_29{left:316px;bottom:655px;letter-spacing:-0.1px;word-spacing:-0.54px;}
#t1p_29{left:316px;bottom:637px;letter-spacing:-0.1px;}
#t1q_29{left:404px;bottom:644px;letter-spacing:-0.12px;}
#t1r_29{left:316px;bottom:618px;letter-spacing:-0.1px;}
#t1s_29{left:316px;bottom:524px;letter-spacing:-0.09px;}
#t1t_29{left:316px;bottom:506px;letter-spacing:-0.1px;}
#t1u_29{left:404px;bottom:514px;letter-spacing:-0.12px;}
#t1v_29{left:316px;bottom:488px;letter-spacing:-0.09px;}
#t1w_29{left:316px;bottom:444px;letter-spacing:-0.06px;}
#t1x_29{left:316px;bottom:401px;letter-spacing:-0.1px;}
#t1y_29{left:380px;bottom:408px;}
#t1z_29{left:324px;bottom:313px;letter-spacing:-0.1px;}
#t20_29{left:387px;bottom:320px;}
#t21_29{left:324px;bottom:276px;letter-spacing:-0.1px;}
#t22_29{left:324px;bottom:239px;letter-spacing:-0.09px;}
#t23_29{left:324px;bottom:221px;letter-spacing:-0.09px;}
#t24_29{left:324px;bottom:203px;letter-spacing:-0.09px;}
#t25_29{left:462px;bottom:428px;letter-spacing:-0.1px;}
#t26_29{left:462px;bottom:410px;letter-spacing:-0.09px;}
#t27_29{left:617px;bottom:417px;}
#t28_29{left:446px;bottom:335px;letter-spacing:-0.1px;}
#t29_29{left:446px;bottom:317px;letter-spacing:-0.1px;}
#t2a_29{left:446px;bottom:298px;letter-spacing:-0.09px;}
#t2b_29{left:512px;bottom:306px;}
#t2c_29{left:563px;bottom:377px;letter-spacing:-0.09px;}
#t2d_29{left:563px;bottom:358px;letter-spacing:-0.09px;}
#t2e_29{left:563px;bottom:340px;letter-spacing:-0.11px;}
#t2f_29{left:563px;bottom:301px;letter-spacing:-0.08px;}
#t2g_29{left:563px;bottom:282px;letter-spacing:-0.09px;}
#t2h_29{left:563px;bottom:220px;letter-spacing:-0.35px;}
#t2i_29{left:759px;bottom:367px;letter-spacing:-0.1px;}
#t2j_29{left:925px;bottom:375px;letter-spacing:-0.12px;}
#t2k_29{left:759px;bottom:349px;letter-spacing:-0.09px;}
#t2l_29{left:753px;bottom:310px;letter-spacing:-0.13px;}
#t2m_29{left:776px;bottom:318px;}
#t2n_29{left:753px;bottom:292px;letter-spacing:-0.06px;}
#t2o_29{left:753px;bottom:274px;letter-spacing:-0.1px;}
#t2p_29{left:995px;bottom:281px;letter-spacing:-0.12px;}
#t2q_29{left:1061px;bottom:390px;letter-spacing:-0.1px;}
#t2r_29{left:1061px;bottom:372px;letter-spacing:-0.09px;}
#t2s_29{left:1061px;bottom:354px;letter-spacing:-0.08px;}
#t2t_29{left:1061px;bottom:298px;letter-spacing:-0.09px;}
#t2u_29{left:1061px;bottom:280px;letter-spacing:-0.06px;}
#t2v_29{left:1061px;bottom:261px;letter-spacing:-0.08px;}
#t2w_29{left:1061px;bottom:243px;letter-spacing:-0.09px;}
#t2x_29{left:1061px;bottom:225px;letter-spacing:-0.25px;}
#t2y_29{left:759px;bottom:430px;letter-spacing:-0.13px;}
#t2z_29{left:781px;bottom:437px;}
#t30_29{left:750px;bottom:778px;letter-spacing:0.28px;word-spacing:-0.12px;}
#t31_29{left:1066px;bottom:641px;letter-spacing:-0.09px;word-spacing:-0.11px;}
#t32_29{left:1066px;bottom:623px;letter-spacing:-0.08px;}
#t33_29{left:1066px;bottom:604px;letter-spacing:-0.09px;}
#t34_29{left:1066px;bottom:586px;letter-spacing:-0.25px;}
#t35_29{left:746px;bottom:166px;}
#t36_29{left:755px;bottom:160px;letter-spacing:0.13px;word-spacing:-0.05px;}
#t37_29{left:754px;bottom:143px;letter-spacing:0.08px;word-spacing:0.06px;}
#t38_29{left:880px;bottom:143px;}
#t39_29{left:746px;bottom:133px;}
#t3a_29{left:752px;bottom:127px;letter-spacing:0.12px;}
#t3b_29{left:754px;bottom:110px;letter-spacing:0.12px;}
#t3c_29{left:544px;bottom:622px;letter-spacing:-0.1px;}
#t3d_29{left:544px;bottom:602px;letter-spacing:-0.09px;}
#t3e_29{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_29{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_29{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_29{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_29{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_29{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_29{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_29{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s7_29{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s8_29{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s9_29{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.sa_29{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.sb_29{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sc_29{font-size:15px;font-family:ArialMT_k0;color:#000;}
.sd_29{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts29" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: ArialMT_k0;
	src: url("fonts/ArialMT_k0.woff") format("woff");
}

</style>
<div id="pg29Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg29" style="-webkit-user-select: none;"><object width="1210" height="935" data="29/29.svg" type="image/svg+xml" id="pdf29" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_29" class="t s0_29">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_29" class="t s1_29">® </span>
<span id="t3_29" class="t s0_29">(NCCN </span>
<span id="t4_29" class="t s1_29">® </span>
<span id="t5_29" class="t s0_29">), All rights reserved. NCCN Guidelines </span>
<span id="t6_29" class="t s1_29">® </span>
<span id="t7_29" class="t s0_29">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_29" class="t s2_29">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_29" class="t s2_29">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_29" class="t s3_29">NCCN Guidelines Version 4.2024 </span>
<span id="tb_29" class="t s3_29">Cancer of the Hypopharynx </span>
<span id="tc_29" class="t s4_29">NCCN Guidelines Index </span>
<span id="td_29" class="t s4_29">Table of Contents </span>
<span id="te_29" class="t s4_29">Discussion </span>
<span id="tf_29" class="t s5_29">HYPO-4 </span>
<span id="tg_29" class="t s6_29">h </span>
<span id="th_29" class="t s7_29">Principles of Radiation Therapy (HYPO-A)</span><span id="ti_29" class="t s8_29">. </span>
<span id="tj_29" class="t s6_29">i </span>
<span id="tk_29" class="t s7_29">Principles of Surgery (SURG-A)</span><span id="tl_29" class="t s8_29">. </span>
<span id="tm_29" class="t s6_29">j </span>
<span id="tn_29" class="t s8_29">Adverse pathologic features: extranodal extension, positive margins, close margins, pT3 or pT4 </span>
<span id="to_29" class="t s8_29">primary, pN2 or pN3 nodal disease, perineural invasion, vascular invasion, and lymphatic invasion </span>
<span id="tp_29" class="t s7_29">(Discussion)</span><span id="tq_29" class="t s8_29">. </span>
<span id="tr_29" class="t s5_29">RESPONSE </span>
<span id="ts_29" class="t s5_29">ASSESSMENT </span>
<span id="tt_29" class="t s5_29">Response </span>
<span id="tu_29" class="t s5_29">after </span>
<span id="tv_29" class="t s5_29">induction </span>
<span id="tw_29" class="t s5_29">chemo- </span>
<span id="tx_29" class="t s5_29">therapy </span>
<span id="ty_29" class="t s9_29">k,l </span>
<span id="tz_29" class="t s5_29">for T2–3, </span>
<span id="t10_29" class="t s5_29">N0–3 </span>
<span id="t11_29" class="t s5_29">or T1,N+ </span>
<span id="t12_29" class="t s5_29">Primary site: </span>
<span id="t13_29" class="t s5_29">Complete </span>
<span id="t14_29" class="t s5_29">response </span>
<span id="t15_29" class="t s5_29">(CR) and </span>
<span id="t16_29" class="t s5_29">stable or </span>
<span id="t17_29" class="t s5_29">improved </span>
<span id="t18_29" class="t s5_29">disease in </span>
<span id="t19_29" class="t s5_29">neck </span>
<span id="t1a_29" class="t s5_29">Primary site: </span>
<span id="t1b_29" class="t s5_29">Partial </span>
<span id="t1c_29" class="t s5_29">response </span>
<span id="t1d_29" class="t s5_29">(PR) and </span>
<span id="t1e_29" class="t s5_29">stable or </span>
<span id="t1f_29" class="t s5_29">improved </span>
<span id="t1g_29" class="t s5_29">disease in </span>
<span id="t1h_29" class="t s5_29">neck </span>
<span id="t1i_29" class="t s5_29">Primary site: </span>
<span id="t1j_29" class="t s5_29">&lt; PR </span>
<span id="t1k_29" class="t sa_29" data-mappings='[[2,"fi"]]'>Deﬁnitive RT </span>
<span id="t1l_29" class="t s9_29">h </span>
<span id="t1m_29" class="t s5_29">(category 1) </span>
<span id="t1n_29" class="t s5_29">or </span>
<span id="t1o_29" class="t s5_29">Consider systemic </span>
<span id="t1p_29" class="t s5_29">therapy/RT </span>
<span id="t1q_29" class="t s9_29">h,k </span>
<span id="t1r_29" class="t s5_29">(category 2B) </span>
<span id="t1s_29" class="t s5_29">Systemic </span>
<span id="t1t_29" class="t s5_29">therapy/RT </span>
<span id="t1u_29" class="t s9_29">h,k </span>
<span id="t1v_29" class="t s5_29">(category 2B) </span>
<span id="t1w_29" class="t s5_29">or </span>
<span id="t1x_29" class="t s5_29">Surgery </span>
<span id="t1y_29" class="t s9_29">i </span>
<span id="t1z_29" class="t s5_29">Surgery </span>
<span id="t20_29" class="t s9_29">i </span>
<span id="t21_29" class="t s5_29">or </span>
<span id="t22_29" class="t s5_29">Unresectable </span>
<span id="t23_29" class="t s5_29">nodal </span>
<span id="t24_29" class="t s5_29">disease </span>
<span id="t25_29" class="t s5_29">No adverse </span>
<span id="t26_29" class="t s5_29">pathologic features </span>
<span id="t27_29" class="t s9_29">j </span>
<span id="t28_29" class="t s5_29">Adverse </span>
<span id="t29_29" class="t s5_29">pathologic </span>
<span id="t2a_29" class="t s5_29">features </span>
<span id="t2b_29" class="t s9_29">j </span>
<span id="t2c_29" class="t s5_29">Extranodal extension </span>
<span id="t2d_29" class="t s5_29">and/or positive </span>
<span id="t2e_29" class="t s5_29">margin </span>
<span id="t2f_29" class="t s5_29">Other risk </span>
<span id="t2g_29" class="t s5_29">features </span>
<span id="t2h_29" class="t sb_29">ADV-1 </span>
<span id="t2i_29" class="t s5_29">Systemic therapy/RT </span>
<span id="t2j_29" class="t s9_29">h,k </span>
<span id="t2k_29" class="t s5_29">(category 1) </span>
<span id="t2l_29" class="t s5_29">RT </span>
<span id="t2m_29" class="t s9_29">h </span>
<span id="t2n_29" class="t s5_29">or </span>
<span id="t2o_29" class="t s5_29">Consider systemic therapy/RT </span>
<span id="t2p_29" class="t s9_29">h,k </span>
<span id="t2q_29" class="t s5_29">Follow-up </span>
<span id="t2r_29" class="t sb_29">(FOLL-A, 1 </span>
<span id="t2s_29" class="t sb_29">of 2) </span>
<span id="t2t_29" class="t s5_29">Recurrent </span>
<span id="t2u_29" class="t s5_29">or </span>
<span id="t2v_29" class="t s5_29">persistent </span>
<span id="t2w_29" class="t s5_29">disease </span>
<span id="t2x_29" class="t sb_29">(ADV-3) </span>
<span id="t2y_29" class="t s5_29">RT </span>
<span id="t2z_29" class="t s9_29">h </span>
<span id="t30_29" class="t s5_29">ADJUVANT TREATMENT </span>
<span id="t31_29" class="t s5_29">Recurrent or </span>
<span id="t32_29" class="t s5_29">persistent </span>
<span id="t33_29" class="t s5_29">disease </span>
<span id="t34_29" class="t sb_29">(ADV-3) </span>
<span id="t35_29" class="t s6_29">k </span>
<span id="t36_29" class="t s7_29">Principles of Systemic Therapy for Non-Nasopharyngeal </span>
<span id="t37_29" class="t s7_29">Cancers (SYST-A)</span><span id="t38_29" class="t s8_29">. </span>
<span id="t39_29" class="t s6_29">l </span>
<span id="t3a_29" class="t sc_29">In randomized clinical trials, assessment of response has </span>
<span id="t3b_29" class="t s8_29">been done after 2 or 3 cycles. </span>
<span id="t3c_29" class="t sb_29">Post Systemic Therapy/RT or RT </span>
<span id="t3d_29" class="t sb_29">Neck Evaluation (FOLL-A, 2 of 2) </span>
<span id="t3e_29" class="t sd_29">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
